Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Atrion Corporation Declares Quarterly Cash Dividend

Posted on: 08 Nov 17

ALLEN, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq:ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $1.20 per share on the Company’s outstanding Common Stock.  This dividend will be payable on December 15, 2017 to stockholders of record at the close of business on December 1, 2017.

Atrion Corporation develops and manufactures products primarily for medical applications.  The Company’s website is

Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800


Last updated on: 08/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.